Premium
Cognitive‐behavioural therapy in patients with inflammatory bowel diseases: A systematic review and meta‐analysis
Author(s) -
Li Chenyang,
Hou Zhenhua,
Liu Yanhui,
Ji Yunan,
Xie Lingli
Publication year - 2019
Publication title -
international journal of nursing practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.62
H-Index - 55
eISSN - 1440-172X
pISSN - 1322-7114
DOI - 10.1111/ijn.12699
Subject(s) - medicine , meta analysis , inflammatory bowel disease , cochrane library , anxiety , physical therapy , funnel plot , disease , cognition , cognitive behavioral therapy , publication bias , randomized controlled trial , psychiatry
Aims This systematic review and meta‐analysis aimed to evaluate the effects of cognitive‐behavioural therapy in patients with inflammatory bowel diseases. Methods Cochrane Library, Web of Science, Pubmed, EMBASE, and CINAHL were searched up to June 2017, as well as grey literature and databases hand searches. Quality assessment, heterogeneity, sensitivity analysis, and publication bias were performed. Stata12.0 software was used for pooled estimates. Results Seven eligible reports were included in the final analysis. Inflammatory Bowel Disease Questionnaire score was higher in the cognitive‐behavioural therapy group than in the control group at the final follow‐up in inflammatory bowel disease patients ( P = 0.008). There was no statistically significant difference in the Crohn's Disease Activity Index ( P = 0.751), Simple Clinical Colitis Activity Index score ( P = 0.747), State Anxiety score ( P = 0.988), Trait Anxiety score ( P = 0.681), and Perceived Stress Questionnaire score ( P = 0.936) at the final point of follow‐up. A funnel plot showed no publication bias ( P = 0.98). Conclusion Cognitive‐behavioural therapy appeared to support higher quality of life in inflammatory bowel disease patients compared with a control group at the final follow‐up point but had no effect on disease activity, anxiety, or perceived stress in patients with inflammatory bowel disease. Cognitive‐behavioural therapy can be an acceptable adjunctive therapy for inflammatory bowel disease patients, but the effect of cognitive‐behavioural therapy is limited.